Investigative Site: #60 — Portland, Oregon

Investigative Site: #60 is a clinical research site located in Portland, Oregon, United States 97239.

Crixeo Health Trust Score: 54/100 (POOR). This profile has not yet been claimed by the site owner.

Investigative Site: #60 has participated in 1 clinical trials.

Therapeutic areas: KRAS Positive Patients With Non-small Cell Lung Cancer, Squamous Cell Non-small Cell Lung Cancer.

Sponsors: BIND Therapeutics.

Sponsor Feasibility Report

Trust Score: 54/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for Investigative Site: #60?

Investigative Site: #60 has a Crixeo Trust Score of 54/100 (POOR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has Investigative Site: #60 conducted?

Investigative Site: #60 has 1 clinical trials on record. Their work covers KRAS Positive Patients With Non-small Cell Lung Cancer, Squamous Cell Non-small Cell Lung Cancer.

Is Investigative Site: #60 accredited by Crixeo Health?

Investigative Site: #60 has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about Investigative Site: #60?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.